0001209191-18-018673.txt : 20180309 0001209191-18-018673.hdr.sgml : 20180309 20180309205024 ACCESSION NUMBER: 0001209191-18-018673 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180306 FILED AS OF DATE: 20180309 DATE AS OF CHANGE: 20180309 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Patni Rajiv CENTRAL INDEX KEY: 0001616200 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36399 FILM NUMBER: 18681719 MAIL ADDRESS: STREET 1: C/O OCERA THERAPEUTICS, INC. STREET 2: 525 UNIVERSITY AVENUE, SUITE 610 CITY: PALO ALTO STATE: CA ZIP: 94301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc CENTRAL INDEX KEY: 0001328143 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 421560076 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 BUSINESS PHONE: 510-450-3554 MAIL ADDRESS: STREET 1: 1900 POWELL ST., SUITE 750 CITY: EMERYVILLE STATE: CA ZIP: 94608 FORMER COMPANY: FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc DATE OF NAME CHANGE: 20050524 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-06 0 0001328143 Adamas Pharmaceuticals Inc ADMS 0001616200 Patni Rajiv C/O ADAMAS PHARMACEUTICALS, INC. 1900 POWELL ST, STE 750 EMERYVILLE CA 94608 0 1 0 0 Chief Medical Officer Common Stock 2018-03-06 4 A 0 9125 0.00 A 22767 D Stock Option (Right to Buy) 25.66 2018-03-06 4 A 0 54750 0.00 A 2028-03-05 Common Stock 54750 54750 D The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2019, March 20, 2020, March 20, 2021 and March 20, 2022, subject to Reporting Person's Continuous Service as of each such date. The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with April 1, 2018, subject to Reporting Person's Continuous Service as of each such date. /s/Jennifer Rhodes, as Attorney-in-Fact 2018-03-09